Literature DB >> 20350805

A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH.

Fa Liu1, Ramin Mollaaghababa Hakami, Beverly Dyas, Medhanit Bahta, George T Lountos, David S Waugh, Robert G Ulrich, Terrence R Burke.   

Abstract

A bivalent tethered approach toward YopH inhibitor development is presented that joins aldehydes with mixtures of bis-aminooxy-containing linkers using oxime coupling. The methodology is characterized by its facility and ease of use and its ability to rapidly identify low micromolar affinity inhibitors. The generality of the approach may potentially make it amenable to the development of bivalent inhibitors directed against other phosphatases. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350805      PMCID: PMC2863121          DOI: 10.1016/j.bmcl.2010.03.058

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Combinatorial target-guided ligand assembly: identification of potent subtype-selective c-Src inhibitors.

Authors:  D J Maly; I C Choong; J A Ellman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Authors:  James Seidler; Susan L McGovern; Thompson N Doman; Brian K Shoichet
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

3.  Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.

Authors:  Steven M Johnson; H Michael Petrassi; Satheesh K Palaninathan; Nilofar N Mohamedmohaideen; Hans E Purkey; Christopher Nichols; Kyle P Chiang; Traci Walkup; James C Sacchettini; K Barry Sharpless; Jeffery W Kelly
Journal:  J Med Chem       Date:  2005-03-10       Impact factor: 7.446

Review 4.  Protein tyrosine phosphatases: emerging regulators of apoptosis.

Authors:  Maxime Hallé; Michel L Tremblay; Tzu-Ching Meng
Journal:  Cell Cycle       Date:  2007-08-19       Impact factor: 4.534

5.  Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.

Authors:  Hongyu Zhao; Gang Liu; Zhili Xin; Michael D Serby; Zhonghua Pei; Bruce G Szczepankiewicz; Philip J Hajduk; Cele Abad-Zapatero; Charles W Hutchins; Thomas H Lubben; Stephen J Ballaron; Deanna L Haasch; Wiweka Kaszubska; Cristina M Rondinone; James M Trevillyan; Michael R Jirousek
Journal:  Bioorg Med Chem Lett       Date:  2004-11-15       Impact factor: 2.823

Review 6.  Tethering: fragment-based drug discovery.

Authors:  Daniel A Erlanson; James A Wells; Andrew C Braisted
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

7.  High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide.

Authors:  Jason Phan; Kyeong Lee; Scott Cherry; Joseph E Tropea; Terrence R Burke; David S Waugh
Journal:  Biochemistry       Date:  2003-11-18       Impact factor: 3.162

8.  Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif.

Authors:  Yen Ting Chen; Christopher T Seto
Journal:  Bioorg Med Chem       Date:  2004-06-15       Impact factor: 3.641

9.  Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.

Authors:  T R Burke; M S Smyth; A Otaka; M Nomizu; P P Roller; G Wolf; R Case; S E Shoelson
Journal:  Biochemistry       Date:  1994-05-31       Impact factor: 3.162

10.  Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.

Authors:  T R Burke; H K Kole; P P Roller
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

View more
  7 in total

1.  Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH.

Authors:  Medhanit Bahta; Terrence R Burke
Journal:  ChemMedChem       Date:  2011-06-10       Impact factor: 3.466

2.  Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.

Authors:  Medhanit Bahta; Fa Liu; Sung-Eun Kim; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

3.  Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Authors:  Medhanit Bahta; George T Lountos; Beverly Dyas; Sung-Eun Kim; Robert G Ulrich; David S Waugh; Terrence R Burke
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

4.  Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.

Authors:  Stephanie M Stanford; Divya Krishnamurthy; Matthew D Falk; Rossella Messina; Bikash Debnath; Sheng Li; Tong Liu; Roza Kazemi; Russell Dahl; Yantao He; Xiao Yu; Andrew C Chan; Zhong-Yin Zhang; Amy M Barrios; Virgil L Woods; Nouri Neamati; Nunzio Bottini
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

5.  Inhibitors of the Yersinia protein tyrosine phosphatase through high throughput and virtual screening approaches.

Authors:  Xin Hu; Milos Vujanac; Noel Southall; C Erec Stebbins
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

6.  Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH.

Authors:  Sung Eun Kim; Medhanit Bahta; George T Lountos; Robert G Ulrich; Terrence R Burke; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-06-11

7.  Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.

Authors:  Megan Hogan; Medhanit Bahta; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Terrence R Burke; David S Waugh; Robert G Ulrich
Journal:  Chem Biol Drug Des       Date:  2013-03       Impact factor: 2.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.